Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT02229981
Title An Early-Phase Clinical Trial Evaluating ABC294640 in Patients With Refractory/Relapsed Diffuse Large B-cell Lymphoma
Acronym ABC-102
Recruitment Withdrawn
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors RedHill Biopharma Limited
Age Groups: adult
Covered Countries USA

No variant requirements are available.